Evidence map›Paper›PMID 38446058›Full record

ArticleJournal of bacteriology2024

Jashwin Sagoo, Samar Abedrabbo, Xiaolin Liu, Karen M Ottemann

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Characterization ofJournal of bacteriology · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jashwin Sagoo *Department of Microbiology and Environmental Toxicology, UC Santa Cruz, Santa Cruz, California, USA.ORCID 0009-0000-0792-153X
Samar Abedrabbo *Department of Microbiology and Environmental Toxicology, UC Santa Cruz, Santa Cruz, California, USA.
Xiaolin LiuDepartment of Microbiology and Environmental Toxicology, UC Santa Cruz, Santa Cruz, California, USA.ORCID 0000-0001-5891-4559
Karen M OttemannDepartment of Microbiology and Environmental Toxicology, UC Santa Cruz, Santa Cruz, California, USA.ORCID 0000-0001-6265-7401
University of California, Santa Cruz · US

Funding

The function of chemotactic signal transduction during colonization and diseaseR01AI116946 · NIAID · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI OTTEMANN, KAREN M · 2016 to 2025
$5.1M
Understanding and manipulating chronic Helicobacter pylori to enhance treatmentR01AI164682 · NIAID · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI OTTEMANN, KAREN M · 2021 to 2025
$2.0M
NIAID NIH HHS R01 AI116946NIAID NIH HHS R01 AI164682
6 · The paper itself

Abstract

The bacterial chemotaxis system is a well-understood signaling pathway that promotes bacterial success. Chemotaxis systems comprise chemoreceptors and the CheA kinase, linked by CheW or CheV scaffold proteins. Scaffold proteins provide connections between chemoreceptors and CheA and also between chemoreceptors to create macromolecular arrays. Chemotaxis is required for host colonization by many microbes, including the stomach pathogen IMPORTANCE: Chemotactic motility, present in over half of bacteria, depends on chemotaxis signaling systems comprising receptors, kinases, and scaffold proteins. In

Indexed as

Escherichia coli ProteinsHelicobacter pyloriAgarBacterial ProteinsChemoreceptor CellsChemotaxisHistidine KinaseMembrane ProteinsMethyl-Accepting Chemotaxis ProteinsAgarBacterial ProteinsEscherichia coli ProteinsHistidine KinaseMembrane ProteinsMethyl-Accepting Chemotaxis Proteinschemotaxisflagellar motilityspontaneous mutations

Identifiers

PMID38446058
PMCPMC11025336
OpenAlexW4392519345

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.